Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Government fights measles outbreak with MMR catch-up campaign

Public health The MMR catch-up campaign is targeting more than 1 million children and teenagers who are unprotected against measles in an effort to combat the rising number of cases across England.

The government has launched a national MMR catch-up campaign to target more than one million children and teenagers who are unprotected against measles in an effort to combat the rising number of cases across England.


Public Health England (PHE), NHS England and the Department of Health are targeting 10 to 16-year-olds across the country who have never received the MMR vaccination or need one further dose to be protected, they announced yesterday (April 24).   


This year, 587 cases of measles were recorded in England by the end of March, with the highest number of cases in the north east and north west and a peak in 10 to 14-year-olds, according to the latest figures from PHE.


Experts blame the measles outbreak on widespread concerns about the discredited link between autism and the MMR vaccine

More on the measles epidemic

Pharmacists lead charge against measles in Wales

Measles cases soar

Chris Chapman: How do pharmacists approach       public health issues?

Eighteen per cent of people with measles have been hospitalised, with 15 people suffering from complications such as pneumonia, meningitis and gastroenteritis. This follows last year's record high of nearly 2,000 cases in England.


In Wales there have been 981 confirmed cases in the past six months, resulting in the death of one 25-year-old man.


Experts blame the current outbreak on widespread concerns about the discredited link between autism and the MMR vaccine during the late 1990s and early 2000s, which meant many children and teenagers went unprotected.  


PHE estimates there are 300,000 unvaccinated children aged 10 to 16 years, and a similar number who need at least one further dose to give them full protection. Meanwhile there are another 300,000 outside this age group who need at least one further dose of the MMR vaccine.


The catch-up programme will see local groups led by NHS England area teams, together with local government directors of public health and PHE centres, identifying and giving the jab to 10 to 16-year-olds through their GPs or schools. Further action will be taken if the vaccination needs to be extended to those beyond this age bracket, PHE said.


"Measles is a potentially fatal but entirely preventable disease so we are very disappointed that measles cases have recently increased in England," PHE head of immunisation Mary Ramsay said.


"The only way to prevent measles outbreaks, such as the one we are seeing in south Wales, is to ensure good uptake of the MMR vaccine across all age groups," she said.


PHE has set up a Facebook page and Twitter hashtag #getthemmr to encourage vaccine take-up.


Have you seen an increase in patient inquiries about MMR vaccination?

Comment below or email us at [email protected] You can also find C+D on Twitter, LinkedIn and Facebook

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD016167

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel